-
公开(公告)号:US20120135989A1
公开(公告)日:2012-05-31
申请号:US13172007
申请日:2011-06-29
申请人: Yoko Funakoshi , Chika Tanaka , Choul Hong Park , Seong Gu Ro
发明人: Yoko Funakoshi , Chika Tanaka , Choul Hong Park , Seong Gu Ro
IPC分类号: A61K31/5377 , C07D487/04 , A61P35/00 , A61K31/496 , A61K31/519 , C07D471/04 , A61K31/437
CPC分类号: C07D471/04 , C07D487/04
摘要: The present invention provides a (di)azaindole derivative represented by the formula (I). A compound of the present invention inhibits a Cdc7 protein kinase activity and suppresses cell proliferation.
摘要翻译: 本发明提供由式(I)表示的(二)氮杂吲哚衍生物。 本发明的化合物抑制Cdc7蛋白激酶活性并抑制细胞增殖。
-
公开(公告)号:US20140018533A1
公开(公告)日:2014-01-16
申请号:US14008488
申请日:2012-03-30
申请人: Takayuki Irie , Ayako Sawa , Masaaki Sawa , Tokiko Asami , Yoko Funakoshi , Chika Tanaka
发明人: Takayuki Irie , Ayako Sawa , Masaaki Sawa , Tokiko Asami , Yoko Funakoshi , Chika Tanaka
IPC分类号: C07D471/04
CPC分类号: C07D471/04 , A61K31/437 , A61K31/4375 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5355 , A61K31/541 , C07D519/00
摘要: To provide a novel furanone derivative, and a medicine including the same. The furanone derivative is represented by the formula (I): wherein A represents —COOR1 or a hydrogen atom; R1 represents a hydrogen atom, an optionally substituted hydrocarbon group, or an optionally substituted heterocycle; R2 and R3 are the same or different and each independently represent a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted phenyl group, an optionally substituted heterocycle, an optionally substituted heterocyclic fused ring, or an optionally substituted amino group; or alternatively, R2 and R3, taken together with the nitrogen atom to which they are attached, may form an optionally substituted heterocycle or an optionally substituted heterocyclic fused ring; and R4 represents a hydrogen atom or a halogen atom; with the proviso that when A represents —COOR1, R2 and R3 are not optionally substituted amino groups at the same time, and when A represents a hydrogen atom, R3 represents a hydrogen atom.
摘要翻译: 提供一种新颖的呋喃酮衍生物,以及包含该呋喃酮衍生物的药物。 呋喃酮衍生物由式(I)表示:其中A表示-COOR 1或氢原子; R1表示氢原子,任选取代的烃基或任选取代的杂环; R2和R3相同或不同,并且各自独立地表示氢原子,任选取代的烃基,任选取代的苯基,任选取代的杂环,任选取代的杂环稠合环或任选取代的氨基; 或者R2和R3与它们所连接的氮原子一起可以形成任选取代的杂环或任选取代的杂环稠环; R4代表氢原子或卤原子; 条件是当A表示-COOR 1时,R2和R3不同时为任选取代的氨基,当A表示氢原子时,R 3表示氢原子。
-
公开(公告)号:US08742113B2
公开(公告)日:2014-06-03
申请号:US14008488
申请日:2012-03-30
申请人: Takayuki Irie , Ayako Sawa , Masaaki Sawa , Tokiko Asami , Yoko Funakoshi , Chika Tanaka
发明人: Takayuki Irie , Ayako Sawa , Masaaki Sawa , Tokiko Asami , Yoko Funakoshi , Chika Tanaka
IPC分类号: C07D471/02 , C07D491/02 , C07D498/02 , C07D513/02 , C07D515/02
CPC分类号: C07D471/04 , A61K31/437 , A61K31/4375 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/496 , A61K31/506 , A61K31/5355 , A61K31/541 , C07D519/00
摘要: To provide a novel furanone derivative, and a medicine including the same. The furanone derivative is represented by the formula (I): wherein A represents —COOR1 or a hydrogen atom; R1 represents a hydrogen atom, an optionally substituted hydrocarbon group, or an optionally substituted heterocycle; R2 and R3 are the same or different and each independently represent a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted phenyl group, an optionally substituted heterocycle, an optionally substituted heterocyclic fused ring, or an optionally substituted amino group; or alternatively, R2 and R3, taken together with the nitrogen atom to which they are attached, may form an optionally substituted heterocycle or an optionally substituted heterocyclic fused ring; and R4 represents a hydrogen atom or a halogen atom; with the proviso that when A represents —COOR1, R2 and R3 are not optionally substituted amino groups at the same time, and when A represents a hydrogen atom, R3 represents a hydrogen atom.
摘要翻译: 提供一种新颖的呋喃酮衍生物,以及包含该呋喃酮衍生物的药物。 呋喃酮衍生物由式(I)表示:其中A表示-COOR 1或氢原子; R1表示氢原子,任选取代的烃基或任选取代的杂环; R2和R3相同或不同,并且各自独立地表示氢原子,任选取代的烃基,任选取代的苯基,任选取代的杂环,任选取代的杂环稠合环或任选取代的氨基; 或者R2和R3与它们所连接的氮原子一起可以形成任选取代的杂环或任选取代的杂环稠环; R4代表氢原子或卤原子; 条件是当A表示-COOR 1时,R2和R3不同时为任选取代的氨基,当A表示氢原子时,R 3表示氢原子。
-
-